Aura Biosciences
(NASDAQ) AURA
Aura Biosciences Financials at a Glance
Market Cap
$466.37M
Revenue (TTM)
$0.00
Net Income (TTM)
$106.19M
EPS (TTM)
$-1.81
P/E Ratio
-4.01
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$7.35
Volume
12,577
Open
$7.48
Price
$7.35
Volume
12,577
Open
$7.48
Previous Close
$7.35
Daily Range
$7.18 - $7.51
52-Week Range
$4.34 - $7.68
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$7.35
Volume
12,577
Open
$7.48
Previous Close
$7.35
Daily Range
$7.18 - $7.51
52-Week Range
$4.34 - $7.68
AURA News
AURA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aura Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
113
CEO
Elisabet de los Pinos, PhD, MBA
Website
www.aurabiosciences.comHeadquarters
Boston, MA 02140, US
AURA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-74%
Return on Capital
-75%
Return on Assets
-63%
Earnings Yield
-24.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$466.37M
Shares Outstanding
64.15M
Volume
12.58K
Short Interest
0.00%
Avg. Volume
267.30K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$112.79M
EBITDA
$111.66M
Operating Cash Flow
$84.74M
Capital Expenditure
$447.00K
Free Cash Flow
$85.19M
Cash & ST Invst.
$144.24M
Total Debt
$17.38M
Aura Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$600.00K
+306.2%
Gross Margin
0.00%
N/A
Market Cap
$466.37M
N/A
Market Cap/Employee
$4.40M
N/A
Employees
106
N/A
Net Income
$25.56M
+1.1%
EBITDA
$26.96M
-5.7%
Quarterly Fundamentals
Net Cash
$126.86M
-4.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$14.13M
-9.5%
Short Term Debt
$3.24M
+3.0%
Return on Assets
-62.68%
N/A
Return on Invested Capital
-74.67%
N/A
Free Cash Flow
$20.64M
+14.9%
Operating Cash Flow
$20.47M
+14.5%